Insights into structural dynamics of allosteric binding sites in HCV RNA-dependent RNA polymerase
暂无分享,去创建一个
Charu Suri | Sankar Bhattacharya | Anita Kumari | Shailendra Asthana | Lovika Mittal | A. Kumari | Lovika Mittal | Shailendra Asthana | C. Suri | S. Bhattacharya
[1] Huanxiang Liu,et al. Computational study on the drug resistance mechanism of hepatitis C virus NS5B RNA-dependent RNA polymerase mutants to BMS-791325 by molecular dynamics simulation and binding free energy calculations , 2016 .
[2] Uwe Koch,et al. Interdomain Communication in Hepatitis C Virus Polymerase Abolished by Small Molecule Inhibitors Bound to a Novel Allosteric Site* , 2005, Journal of Biological Chemistry.
[3] David E. Shaw,et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results , 2006, J. Comput. Aided Mol. Des..
[4] P. Kumaradhas,et al. Probing the “fingers” domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations , 2018, Journal of biomolecular structure & dynamics.
[5] F. Rey,et al. Structural Analysis of the Hepatitis C Virus RNA Polymerase in Complex with Ribonucleotides , 2002, Journal of Virology.
[6] B. Prasad,et al. RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution , 2018, Viruses.
[7] R. Shafer,et al. Baseline dasabuvir resistance in Hepatitis C virus from the genotypes 1, 2 and 3 and modeling of the NS5B-dasabuvir complex by the in silico approach , 2018, Infection ecology & epidemiology.
[8] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[9] Matthew P. Repasky,et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.
[10] E. El-Bastawissy,et al. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein–ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation , 2018, Journal of biomolecular structure & dynamics.
[11] Meitian Wang,et al. Non-nucleoside inhibitors binding to hepatitis C virus NS5B polymerase reveal a novel mechanism of inhibition. , 2006, Journal of molecular biology.
[12] P. Ruggerone,et al. Different molecular mechanisms of inhibition of bovine viral diarrhea virus and hepatitis C virus RNA-dependent RNA polymerases by a novel benzimidazole. , 2013, Biochemistry.
[13] Jóhannes Reynisson,et al. Benchmarking the reliability of QikProp. Correlation between experimental and predicted values , 2008 .
[14] Meitian Wang,et al. Crystal Structures of the RNA-dependent RNA Polymerase Genotype 2a of Hepatitis C Virus Reveal Two Conformations and Suggest Mechanisms of Inhibition by Non-nucleoside Inhibitors* , 2005, Journal of Biological Chemistry.
[15] D. Davis,et al. Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase. , 2014, Journal of medicinal chemistry.
[16] Federico D. Sacerdoti,et al. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters , 2006, ACM/IEEE SC 2006 Conference (SC'06).
[17] J. Bruenn. A structural and primary sequence comparison of the viral RNA-dependent RNA polymerases. , 2003, Nucleic acids research.
[18] Mitul Srivastava,et al. Molecular dynamics simulation reveals the possible druggable hot-spots of USP7 , 2018, Oncotarget.
[19] F. Ceccherini‐Silberstein,et al. Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors , 2014, Antimicrobial Agents and Chemotherapy.
[20] April Wong,et al. Slow Binding Inhibition and Mechanism of Resistance of Non-nucleoside Polymerase Inhibitors of Hepatitis C Virus , 2009, The Journal of Biological Chemistry.
[21] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[22] P. Ruggerone,et al. Molecular mechanism of viral resistance to a potent non-nucleoside inhibitor unveiled by molecular simulations. , 2014, Biochemistry.
[23] Ian F. Thorpe,et al. Using the Hepatitis C Virus RNA-Dependent RNA Polymerase as a Model to Understand Viral Polymerase Structure, Function and Dynamics , 2015, Viruses.
[24] Potshangbam Angamba Meetei,et al. In silico screening for identification of novel β-1,3-glucan synthase inhibitors using pharmacophore and 3D-QSAR methodologies , 2016, SpringerPlus.
[25] C. Kao,et al. Mechanism of De Novo Initiation by the Hepatitis C Virus RNA-Dependent RNA Polymerase: Role of Divalent Metals , 2002, Journal of Virology.
[26] Mikael Bodén,et al. MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..
[27] Zhen-ming Chen,et al. Combined 3D-QSAR, molecular docking and molecular dynamics study on the benzimidazole inhibitors targeting HCV NS5B polymerase , 2019, Journal of biomolecular structure & dynamics.
[28] Hui Li,et al. Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. , 2009, Journal of medicinal chemistry.
[29] R. Hamatake,et al. Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymerase. , 2014, Journal of medicinal chemistry.
[30] Steven L Dixon,et al. PHASE: A Novel Approach to Pharmacophore Modeling and 3D Database Searching , 2006, Chemical biology & drug design.
[31] Jennifer L. Knight,et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.
[32] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[33] Y. Waheed,et al. RNA dependent RNA polymerase of HCV: a potential target for the development of antiviral drugs. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[34] Kyoung Tai No,et al. Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation. , 2009, Bioorganic & medicinal chemistry.
[35] Jiqin Wu,et al. A Structural Overview of RNA-Dependent RNA Polymerases from the Flaviviridae Family , 2015, International journal of molecular sciences.